In vitro and in vivo activities of ticarcillin-loaded nanoliposomes with different surface charges against pseudomonas aeruginosa (ATCC 29248)

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

  Gharib, Amir ^a   Faezizadeh, Zohreh ^a   Godarzee, Masoud ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Killing rate; Nanoliposome; Pseudomonas aeruginosa; Surface charge; Ticarcillin

Indexed keywords

LIPOSOME; TICARCILLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BROTH DILUTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SURFACE CHARGE; SURVIVAL RATE; ZETA POTENTIAL;

EID: 84892054998     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-20-41     Document Type: Article

References (29)

1. Alipour M, Suntres ZE, Lafrenie RM, Omri A: Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes. J Antimicrob Chemother 2010, 65:684-693.
2. Moore NM, Flaws ML: Antimicrobial resistance mechanisms in Pseudomonas aeruginosa. Clin Lab Sci 2011, 24:47-51.
3. Moore NM, Flaws ML: Epidemiology and pathogenesis of Pseudomonas aeruginosa infections. Clin Lab Sci 2011, 24:43-46.
4. Manuel J, Zhanel GG, de Kievit, T: Cadaverine suppresses persistence to carboxypenicillins in Pseudomonas aeruginosa PAO1. Antimicrob Agent Chemother 2010, 54:5173-5179.
5. Karr JC, Lauretta J, Keriazes G: In vitro antimicrobial activity of calcium sulfate and hydroxyapatite (Cerament Bone Void Filler) discs using heatsensitive and non-heat-sensitive antibiotics against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. J Am Podiatr Med Assoc 2011, 101:146-152.
6. Slain D, Sarwari AR, Petros KO, McKnight RL, Sager RB, Mullett CJ: Impact of a multimodal antimicrobial stewardship srogram on Pseudomonas aeruginosa susceptibility and antimicrobial use in the intensive care unit setting. Crit Care Res Pract 2011, 2011:416-426.
7. Pumerantz A, Muppidi K, Agnihotri S, Guerra C, Venketaraman V, Wang J: Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2011, 37:140-144.
8. Gaffari MA, Dabbagh MA, Gharib A: Human erythrocyte superoxide dismutase encapsulated in positively charged liposomes. Iranian J Pharm Sci 2005, 1:153-160.
9. Mirzaee M, Owlia P, Mehrabi MR, Gharib A: In Vitro bactericidal activity of encapsulated amikacin in liposome. Iranian J Pathol 2009, 4:151-156.
10. Sarbolouki MN, Maghdooni Bagheri P, Saneei V: The influence of lipid composition and beta-carotene on lipid peroxidation in liposomes. DARU J Pharm Sci 2005, 13:184-154.
11. Tamaddon AM, Hosseini-Shirazi F, Moghimi HR: Preparation of oligodeoxynucleotide encapsulatedcationic liposomes and release study with models of cellular membranes. DARU J Pham Sci 2007, 15:61-70. (Pubitemid 47075880)
12. Zhong Z, Wan Y, Han J, Shi S, Zhang Z, Sun X: Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes. Int J Nanomedicine 2011, 6:1083-1093.
13. Roychoudhury J, Sinha R, Ali N: Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice. PLoS One 2011, 6:e17376.
14. Huang CM, Chen CH, Pornpattananangkul D, Zhang L, Chan M, Hsieh MF: Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials 2011, 32:214-221.
15. Gubernator J: Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity. Expert Opin Drug Deliv 2011, 8:565-580.
16. Maestrelli F, Capasso G, Gonzalez-Rodriguez ML, Rabasco AM, Ghelardini C, Mura P: Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Liposome Res 2009, 4:1-8.
17. McWhinney BC, Wallis SC, Hillister T, Roberts JA, Lipman J, Ungerer JP: Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:2039-2043.
18. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard-6th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2003. NCCLS document M7-A6.
19. Shrivastava SM, Saurabh S, Rai D, Dwivedi VK, Chaudhary M: In vitro microbial efficacy of sulbactomax: A novel fixed dose combination of ceftriaxone sulbactam and ceftriaxone alone. Cur Drug Ther 2009, 4:73-77.
20. Dale RK, Schnell G, Wong JP: Therapeutic Efficacy of " Nubiotics" against Burn Wound Infection by Pseudomonas aeruginosa. Antimicrob Agents Chemother 2004, 48:2918-2923. (Pubitemid 38989156)
21. Committe on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources: Commission on Life Sciences National Research Council. Guide for the care and use of laboratory animals. Washington, D.C: National Academy Press; 1996.
22. Shaffa MW, Dayem SA, Elshemy WM: In vitro antibacterial activity of liposomal cephalexin against Staphylococcus aureus. Romanian J Biophys 2008, 18:293-300.
23. Gharib A, Faezizadeh Z, Mohammad Asghari H: Preparation and antifungal activity of spray-dried amphotericin B-loaded nanospheres. DARU J Pharm Sci 2011, 19:351-355.
24. Drulis-Kawa Z, Dorotkiewicz-Jach A, Gubernator J, Gula G, Bocer T, Doroszkiewicz W: The interaction between Pseudomonas aeruginosa cells and cationic PC:Chol:DOTAP liposomal vesicles versus outer-membrane structure and envelope properties of bacterial cell. Int J Pharm 2009, 367:211-219.
25. Klein DG, Fritsh DE, Amin SG: Wound infection following trauma and burn injuries. Crit Care Nursing N Am 1995, 7:627-642.
26. Pruitt BA, McManus AT, Kim SH, Goodwin CW: Burn wound infections: current status. World J Surg 1998, 22:135-145. (Pubitemid 28065179)
27. Wurtz RE, Karajovic E, Dacumos, Hanumandass M: Nosocomial infections in a burn intensive care unit. Burns 1995, 21:180-184.
28. McVay CS, Velásquez M, Fralick JA: Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model. Antimicrob Agents Chemother 2007, 51:1934-1938. (Pubitemid 46903076)
29. Price CI, Horton JW, Baxter CR: Liposome delivery of aminoglycosides in burn wounds. Surg Gynecol Obstet 1992, 174:414-418.